Evaluation of the effect of Familact synbiotic in treatment of community acquired pneumonia
Phase 3
Recruiting
- Conditions
- community acquired pneumonia.Pneumonia due to Streptococcus pneumoniae
- Registration Number
- IRCT20140623018206N2
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Patients over 18 years old with community-acquired pneumonia diagnosed by an infectious disease specialist and requiring hospitalization (based on CURB-65 criteria)
Patients with the same epidemiological factors (age, gender, and underlying disease) and possible microorganisms
Patients who need one type of treatment and do not need to other treatment such as steroids
Exclusion Criteria
Patients who have taken antibiotics 48 hours before hospitalization
Patients with immunodeficiency (HIV, receiving immunosuppressive drugs, transplantation, chemotherapy, acute pancreatitis), pregnant and lactating women
Patients who have consumed probiotics, prebiotics and synbiotics in the past month
Patients who have not consented
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fever. Timepoint: At first, after 72 hours, and at the end of hospitalization. Method of measurement: Thermometer.;Respiratory Rate. Timepoint: At first, after 72 hours, and at the end of hospitalization. Method of measurement: Respiratory Rate per minute.;White blood cells. Timepoint: After 72 hours of hospitalization. Method of measurement: Laboratory test.;Erythrocyte sedimentation rate. Timepoint: At first, and at the end of hospitalization. Method of measurement: Laboratory test.;C-Reactive Protein. Timepoint: At first, and at the end of hospitalization. Method of measurement: Laboratory test.
- Secondary Outcome Measures
Name Time Method Complications of pneumonia. Timepoint: At the end of study. Method of measurement: Questionnaire.;Duration of hospitalization. Timepoint: During the study. Method of measurement: Questionnaire.